Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease

K Matsushita, SH Ballew, AYM Wang… - Nature Reviews …, 2022 - nature.com
Chronic kidney disease (CKD) is defined by a low glomerular filtration rate or high
albuminuria, and affects 15–20% of adults globally. CKD increases the risk of various …

Chronic kidney disease

P Romagnani, G Remuzzi, R Glassock… - Nature reviews Disease …, 2017 - nature.com
Chronic kidney disease (CKD) is defined by persistent urine abnormalities, structural
abnormalities or impaired excretory renal function suggestive of a loss of functional …

Anabolic–androgenic steroids: How do they work and what are the risks?

P Bond, DL Smit, W de Ronde - Frontiers in Endocrinology, 2022 - frontiersin.org
Anabolic–androgenic steroids (AAS) are a class of hormones that are widely abused for
their muscle-building and strength-increasing properties in high, nontherapeutic, dosages …

Discovery and prioritization of variants and genes for kidney function in> 1.2 million individuals

KJ Stanzick, Y Li, P Schlosser, M Gorski… - Nature …, 2021 - nature.com
Genes underneath signals from genome-wide association studies (GWAS) for kidney
function are promising targets for functional studies, but prioritizing variants and genes is …

The global burden of chronic kidney disease: estimates, variability and pitfalls

RJ Glassock, DG Warnock, P Delanaye - Nature Reviews Nephrology, 2017 - nature.com
Chronic kidney disease (CKD) is currently defined by abnormalities of kidney structure or
function assessed using a matrix of variables—including glomerular filtration rate (GFR) …

Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of …

WC Meijers, A Bayes‐Genis, A Mebazaa… - European journal of …, 2021 - Wiley Online Library
New biomarkers are being evaluated for their ability to advance the management of patients
with heart failure. Despite a large pool of interesting candidate biomarkers, besides …

Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update

R Vanholder, A Pletinck, E Schepers, G Glorieux - Toxins, 2018 - mdpi.com
In this narrative review, the biological/biochemical impact (toxicity) of a large array of known
individual uremic retention solutes and groups of solutes is summarized. We classified these …

[HTML][HTML] Estimating glomerular filtration rate from serum creatinine and cystatin C

LA Inker, CH Schmid, H Tighiouart… - … England Journal of …, 2012 - Mass Medical Soc
Background Estimates of glomerular filtration rate (GFR) that are based on serum creatinine
are routinely used; however, they are imprecise, potentially leading to the overdiagnosis of …

Cystatin C versus creatinine in determining risk based on kidney function

MG Shlipak, K Matsushita, J Ärnlöv… - … England Journal of …, 2013 - Mass Medical Soc
Background Adding the measurement of cystatin C to that of serum creatinine to determine
the estimated glomerular filtration rate (eGFR) improves accuracy, but the effect on …

Kidney disease, race, and GFR estimation

AS Levey, SM Titan, NR Powe, J Coresh… - Clinical Journal of the …, 2020 - journals.lww.com
Assessment of GFR is central to clinical practice, research, and public health. Current
Kidney Disease Improving Global Outcomes guidelines recommend measurement of serum …